Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
ClinicalTrials.gov study NCT05597085. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and
ClinicalTrials.gov study NCT04313608. IPD Sharing: YES. Countries: 1. Publications: 0.
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01014208. IPD Sharing: Not stated. Countries: 26. Publications: 0.
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02129062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response
ClinicalTrials.gov study NCT03701061. IPD Sharing: NO. Countries: 1. Publications: 0.
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00972478. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00998946. IPD Sharing: NO. Countries: 1. Publications: 0.
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
ClinicalTrials.gov study NCT00895661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment
ClinicalTrials.gov study NCT06711354. IPD Sharing: YES. Countries: 0. Publications: 18.
Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02180711. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02207062. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases
ClinicalTrials.gov study NCT03498612. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis
ClinicalTrials.gov study NCT03793270. IPD Sharing: NO. Countries: 0. Publications: 1.
R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00809341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00978432. IPD Sharing: NO. Countries: 1. Publications: 0.
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT00795886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT04432506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma
ClinicalTrials.gov study NCT01560117. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
ClinicalTrials.gov study NCT01239394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunophenotyping of Acute b Cell Lymphoblstic Leukemia
ClinicalTrials.gov study NCT04084327. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.